Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Sitbon

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Revue Des Maladies Respiratoires|February 17, 2020
[Management of right ventricular failure in pulmonary vascular diseases]A Boucly, L Savale, C Vuillard, et al.
The European Respiratory Journal|November 10, 2009
Prognostic factors of acute heart failure in patients with pulmonary arterial hypertensionB Sztrymf, R Souza, L Bertoletti, et al.
Revue Des Maladies Respiratoires|February 1, 2023
[Lung transplantation for severe pulmonary hypertension]J Le Pavec, L Savale, G Prévot, et al.
Circulation|November 15, 2000
Improvement of von Willebrand factor proteolysis after prostacyclin infusion in severe pulmonary arterial hypertensionA Veyradier, T Nishikubo, M Humbert, et al.
Thorax|October 18, 2005
Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosisH Nunes, M Humbert, F Capron, et al.
The European Respiratory Journal|September 4, 1998
Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertensionO Sitbon, M Humbert, J L Jagot, et al.
La Revue De Medecine Interne|September 4, 2018
[Liver diseases and pulmonary vascular disorders]M Riou, E-M Jutant, X Mignard, et al.
Revue Des Maladies Respiratoires|February 27, 2022
[Hepatopulmonary syndrome: Prevalence, pathophysiology and clinical implications]M-C Certain, F Robert, A Baron, et al.
The European Respiratory Journal|August 13, 1999
Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot studyM Humbert, O Sanchez, M Fartoukh, et al.
American Journal of Respiratory and Critical Care Medicine|February 1, 1995
Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclinO Sitbon, F Brenot, A Denjean, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Revue Des Maladies Respiratoires|February 17, 2020
[Management of right ventricular failure in pulmonary vascular diseases]A Boucly, L Savale, C Vuillard, et al.
The European Respiratory Journal|November 10, 2009
Prognostic factors of acute heart failure in patients with pulmonary arterial hypertensionB Sztrymf, R Souza, L Bertoletti, et al.
Revue Des Maladies Respiratoires|February 1, 2023
[Lung transplantation for severe pulmonary hypertension]J Le Pavec, L Savale, G Prévot, et al.
Circulation|November 15, 2000
Improvement of von Willebrand factor proteolysis after prostacyclin infusion in severe pulmonary arterial hypertensionA Veyradier, T Nishikubo, M Humbert, et al.
Thorax|October 18, 2005
Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosisH Nunes, M Humbert, F Capron, et al.
The European Respiratory Journal|September 4, 1998
Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertensionO Sitbon, M Humbert, J L Jagot, et al.
La Revue De Medecine Interne|September 4, 2018
[Liver diseases and pulmonary vascular disorders]M Riou, E-M Jutant, X Mignard, et al.
Revue Des Maladies Respiratoires|February 27, 2022
[Hepatopulmonary syndrome: Prevalence, pathophysiology and clinical implications]M-C Certain, F Robert, A Baron, et al.
The European Respiratory Journal|August 13, 1999
Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot studyM Humbert, O Sanchez, M Fartoukh, et al.
American Journal of Respiratory and Critical Care Medicine|February 1, 1995
Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclinO Sitbon, F Brenot, A Denjean, et al.
Pageof 9